Related Experiment Videos
Pathologic features of early inflammatory bowel disease
Sydney D Finkelstein1, Eizaburo Sasatomi, Miguel Regueiro
1Department of Pathology, Division of Gastroenterology, Nutrition and Hepatology, University of Pittsburgh Medical Center, 200 Lothrop Street, PUH A610.2, Pittsburgh, PA 15213, USA.
Gastroenterology Clinics of North America
|July 19, 2002
Summary
Diagnosing early inflammatory bowel disease (IBD) can be challenging due to subtle pathologic changes. Close collaboration between gastroenterologists and pathologists is crucial for accurate diagnosis and treatment of conditions like ulcerative colitis (UC) and Crohn
Area of Science:
- Gastroenterology and Pathology
- Inflammatory Bowel Disease (IBD) Research
Background:
- Pathologic changes in early inflammatory bowel disease (IBD) can be subtle and may not be detected in all biopsy specimens.
- Missed diagnoses in early disease stages necessitate follow-up biopsies and consideration of modifying factors like prebiopsy treatment.
Purpose of the Study:
- To highlight the challenges in diagnosing early IBD based on pathologic findings.
- To emphasize the importance of clinicopathologic correlation and multidisciplinary communication for accurate IBD diagnosis.
- To underscore the utility of detailed pathologic assessment in evaluating novel IBD therapies.
Main Methods:
- Review of challenging cases in inflammatory bowel disease diagnosis.
- Discussion of factors influencing diagnostic accuracy in biopsy specimens.
- Emphasis on communication between gastroenterologists and pathologists.
Main Results:
- Subtle pathologic changes in early IBD may be missed, requiring repeat biopsies.
- Prebiopsy treatment and coexisting conditions can modify disease presentation.
- Multidisciplinary case review facilitates accurate working diagnoses.
- Detailed pathologic evaluation is essential for assessing new IBD treatments.
Conclusions:
- Accurate diagnosis of early IBD requires careful pathologic examination and consideration of clinical context.
- Enhanced communication between gastroenterologists and pathologists improves diagnostic yield.
- Understanding subtle pathologic features is vital for developing and testing new IBD therapies, including for ulcerative colitis (UC) and Crohn's disease (CD).